论文部分内容阅读
被称为“个性化医疗”的基因检测技术正因为好莱坞影星安吉丽娜·茱莉的手术变得格外引人注目,而基因检测正在成为一桩全球高达300亿美元的流行生意。去年5月中旬,好莱坞影星安吉丽娜·茱莉做出一项轰动全球的决定:切除双侧乳腺。她的乳腺并未病变,但仍然执意手术,支持她的是一次价值4000美元的基因检测:检测结果显示,安吉丽娜体内携带有BRCA1型基因突变。这个肉眼不可见的基因不会影响她的美艳动人,但它会不声不响地增加其乳腺及卵巢癌变的可能性。为她提供检测试剂与仪器的是一家名为凯杰的德国公司。实际上,作为全球领先的样本制备和分析企业,凯杰在分子检测领域还有不少令人颇感兴味的应
Genetic testing, called “personalized medicine,” is just as dramatic as Hollywood star Angelina Jolie’s surgery, which is becoming a popular global business of up to $ 30 billion. In mid-May last year, Hollywood actress Angelina Jolie made a global sensation: removal of both breasts. Her mammary gland was not affected, but she still insisted on surgery, supporting her for a $ 4,000 genetic test: The test showed that Angelina carries a BRCA1-type mutation in her body. This invisible gene does not affect her beauty, but it silently increases the likelihood of cancerous breast and ovarian cancers. To provide her with testing reagents and equipment is a German company called QIJIE. In fact, as the world’s leading sample preparation and analysis company, QIJIE in the field of molecular detection, there are many quite interesting